With AML, the bone marrow develops abnormal myeloid cells called myeloblasts. As the number of myeloblasts increases, the abnormal cells push out healthy cells. This can cause symptoms of AML ...

Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors ...

There are several forms of AML. Each affects a different kind of blood cell. The symptoms you have depend on the type of blood cell that's affected. If you have fewer healthy red blood cells than ...

In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...

Acute myeloid leukemia (AML) is a highly aggressive and difficult-to-treat blood cancer. This study explores the role of ferroptosis-related long non-coding RNAs (lncRNAs) in AML prognosis and ...

Researchers from Karl Landsteiner University of Health Sciences (KL Krems) have discovered that combining two existing drugs ...